Effects of Tibolone on the Breast of Postmenopausal Women
For decades, hormone therapy (HT) has been the mainstay for managing menopausal symptoms. However, the prolonged use of either single estrogen therapy (ET) or a combination therapy of estrogen and progestogen (EPT) might be associated with a slightly increased risk of breast cancer. Alternative ther...
Saved in:
Main Authors: | Peng-Hui Wang (Author), Ming-Huei Cheng (Author), Hsiang-Tai Chao (Author), Kuan-Chong Chao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2007-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Standard and Low-dose Hormone Therapy for Postmenopausal Women-Focus on the Breast
by: Peng-Hui Wang, et al.
Published: (2007) -
The Effect of Tibolon on Bone Mineral Density and Calcium Metabolism in Postmenopausal Women
by: Ahmet C. Çalışkan, et al.
Published: (2003) -
Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009) -
The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene
by: Wen-Ling Lee, et al.
Published: (2008) -
CCDC114, DNAI2 and TOP2A involves in the effects of tibolone treatment on postmenopausal endometrium
by: Yanhua Lv, et al.
Published: (2021)